Journal of Nephrology & Therapeutics

Jiro Toyonaga

Publications

• Research Article
  Long Dialysis Time is the More Important Factor of Erythropoietin Response in Hemodialysis Patients with Diabetes than Kt/V
  Author(s): Atsuhiro Maeda, Kazuhito Takeda, Kazuhiko Tsuruya, Takanari Kitazono, Hideyuki Mukai, Shuuhei Miura, Jiro Toyonaga, Satsuki Nakashita, Tomo Komaki, Keita Takae, Kazuo Sakamoto, Maki Maeda, Nana Oyama and Toshiro MaedaAtsuhiro Maeda, Kazuhito Takeda, Kazuhiko Tsuruya, Takanari Kitazono, Hideyuki Mukai, Shuuhei Miura, Jiro Toyonaga, Satsuki Nakashita, Tomo Komaki, Keita Takae, Kazuo Sakamoto, Maki Maeda, Nana Oyama and Toshiro Maeda
  
  Background: Though inadequate dialysis is a known risk factor for resistance to erythropoietin (EPO) therapy, there is no consensus about the relationship between hemodialysis (HD) time and EPO requirement. Our study sought to explore the relationship between EPO dosage and dialysis time in HD patients with diabetes. Methods: We report a cross-sectional analysis of the relationship between EPO dosage and dialysis time in HD patients with diabetes. A total of 77 patients with diabetes receiving maintenance HD at three outpatient HD facilities in Japan were included. At one such facility, HD time was 6 hours (n=37), and at the other facilities, HD time was 4 hours (n=40). In 6-hour HD patients and 4-hour HD patients, we studied parameters of weekly EPO requirement, Kt/V, hemoglobin, ferritin, albumin, C-reactive protein and intact parathyroid hormone. These parameters were analyzed with.. Read More»
  DOI: 10.4172/2161-0959.1000189

  Abstract PDF